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Summary
Detailed studies on the biosynthesis of the hexa-
saccharide side chain of landomycin A, produced by
S. cyanogenus S136, revealed the function of each
glycosyltransferase gene of the biosynthetic gene
cluster. Analyses of generated mutants as well as
feeding experiments allowed us to determine that
LanGT2 and LanGT3 catalyze the attachment of one
sugar, whereas LanGT1 and LanGT4 attach two
sugars during landomycin A biosynthesis. The gener-
ation of a lanZ2 deletion mutant provided evidence
that LanZ2 is controlling the elongation of the saccha-
ride side chain.
Introduction
Sugar modifications of many antibiotics play essential
roles in maintaining the biological activities of these
compounds [1]. It has been clearly demonstrated that
anthracyclines, glycopeptide antibiotics, aminocouma-
rines, and macrolides require sugar moieties for their
full biological activities [2, 3]. A small but growing num-
ber of natural products with promising antibacterial
activities mainly consists of sugar chains. Examples for
such oligosaccharide antibiotics are the orthosomycins
avilamycin A and evernimicin, the huge polysaccharide
saccharomycin, and the angucyclines urdamycin A and
landomycin A [3–5].
A fundamental challenge in the field of oligosaccha-
ride antibiotics is to identify the exact functions of gly-
cosyltransferases that are involved in the biosynthesis
of the glycan structures. Biosynthetic gene clusters of
a few oligosaccharide antibiotics have been cloned and
sequenced [6–8]. But only the biosynthesis of the urda-
mycin sugar side chain has been investigated in detail,
and it was shown that one glycosyltransferase is
needed for the attachment of each individual sugar [6].
In this study, we are presenting data on the biosyn-
thesis of landomycin A, a compound containing a hexa-*Correspondence: andreas.bechthold@pharmazie.uni-freiburg.de
3 These authors contributed equally to this work.saccharide portion that is produced by Streptomyces
cyanogenus S136 [9]. Landomycin A possesses strong
antitumor activities, in particular against prostate can-
cer cell lines [10]. It inhibits thymidine uptake in murine
smooth-muscle cells and cell-cycle progression. Its un-
usual activities depend on the long oligosaccharide
chain because landomycins with shorter sugar chains,
such as landomycin E (Figure 1) produced by S. globi-
sporus, have much weaker antitumor activity [11].
The sugar portion consists of four D-olivose and two
L-rhodinose moieties (Figure 1). Its formation is ex-
tremely puzzling because only four glycosyltransfer-
ases (LanGT1, LanGT2, LanGT3, and LanGT4) are avail-
able for the six consecutive elongations steps toward
the hexasaccharide [12].
By heterologous expression and gene inactivation,
we could recently demonstrate that LanGT2 is the prim-
ing glycosyltransferase connecting D-olivose to the
landomycin aglycon [13]. We could also show that
LanGT1 is an olivosyltransferase catalyzing the attach-
ment of the second sugar and that LanGT4 is a rhodi-
nosyltransferase attaching the third sugar during lando-
mycin A biosynthesis [13, 14]. Furthermore, a mutant
lacking lanGT3 was accumulating landomycin E, a trun-
cated landomycin derivative with a sugar side chain
comprising the first three sugars only (Figure 1). This
indicates that LanGT3 is the olivosyltransferase re-
sponsible for the transfer of the fourth sugar moiety
[15]. However, despite the elucidation of the sugar sub-
strate specificities of LanGT1, LanGT2, LanGT3, and
LanGT4, it remains elusive as to which GTs account for
the fifth and sixth chain-elongation step.
In this paper, we report results that answer the riddle
of the “six sugars, four glycosyltransferases” paradox:
it is shown by feeding experiments that LanGT1 and
LanGT4 are iteratively acting enzymes both catalyzing
the attachment of two sugar moieties during lando-
mycin A maturation. We also present data on LanZ2,
which apparently controls the smooth course of the
biosynthesis of the hexasaccharide side chain.
Results
Feeding Experiments Revealed LanGT1 and LanGT4
to Be Iteratively Acting Glycosyltransferases
of the Landomycin A Pathway
If one considers that the hexasaccharide side chain of
landomycin A is built up by six consecutive glyco-
syltransfers, it is impossible to identify an iteratively
acting GT solely by inactivation of the respective gene
because the chain elongation would always be stopped
prior to its first glycosyltransfer. No information of a po-
tential second glycosyltransfer would be provided.
Feeding experiments with landomycin derivatives with
varying chain length were performed as an alternative
strategy to overcome this limitation. Landomycin E,
containing a trisaccharide side chain, was fed to the
wild-type (wt) strain and to a lanGT1 and lanGT4 mutant
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726Figure 1. Structures of Different Landomycin Derivativesof S. cyanogenus. The chain elongation of fed landomycin p
rderivatives was monitored by HPLC-MS. Feeding of lan-
domycin E to the wt strain led to its conversion to lando- l
rmycin A (data not shown). This demonstrates that S. cy-
anogenus S136 is able to convert truncated landomycin i
Gderivatives to the full-length final product. However,
feeding of landomycin E to the lanGT1 mutant resulted p
tin the accumulation of landomycin I, the tetrasaccha-
ride congener. This indicates that the fifth sugar s
transfer cannot take place in the absence of LanGT1.
Hence, we conclude that LanGT1 catalyzes also the t
dfifth glycosyltransfer additionally to the second as pre-
viously shown (Figure 2A). After feeding of landomycin p
aE to the lanGT4 mutant, landomycin B containing five
sugars was accumulated. This shows that the final gly- l
mcosyltransfer depends on the presence of LanGT4.
From this result, we can conclude that LanGT4 is also a
bresponsible for the terminal L-rhodinosyltransfer (Fig-
ure 2B). This data clearly documents that both GTs m
sLanGT1 and LanGT4 are iteratively acting during the
hexasaccharide formation of landomycin biosynthesis. w
o
Inactivation of lanZ2 Results in the Production
of Novel Landomycin Derivatives D
The identification of the function of LanZ2, a protein
resembling dNDP-hexose synthases from different clus- T
lters [8], was aimed by targeted gene disruption. This
was achieved by homologous recombination betweenlasmid pKC1132lanZ2 (Experimental Procedures) car-
ying the deleted lanZ2 gene and the chromosomal al-
ele of this gene in S. cyanogenus S136. The mutated
egion in lanZ2 was confirmed by PCR and sequenc-
ng analysis. For complementation, plasmid pKCermE-
T3Z2Z3 consisting of lanZ2 ligated behind the ermE
romotor was introduced into the mutant strain by in-
ergeneric conjugation. This led to the complete recon-
titution of landomycin A production.
The HPLC-MS analyses of the lanZ2 mutant revealed
he production of a different spectrum of landomycin
erivatives compared to the wt strain. The wt strain was
roducing landomycin A (44%), landomycin B (30%),
nd landomycin D (26%). The lanZ2 mutant produced
andomycin A (5.4%), landomycin B (7%), and lando-
ycin D (4%) and, in addition, landomycin F (23.4%)
nd landomycin E (30%). The latter have both never
een described as products of the wt strain. Further-
ore, two new landomycin derivatives with unknown
tructure (30.2%) were produced. From these results,
e have to conclude that LanZ2 impacts the formation
f the sugar side chain.
iscussion
he hexasaccharide portion of landomycin A is the
ongest sugar side chain so far detected among angu-
cycline and anthracycline antibiotics. In our work, we
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727Figure 2. HPLC-MS Chromatograms of Extracts after Feeding of Landomycin E to the lanGT1 and lanGT4 Mutants
HPLC-MS chromatograms of extracts after feeding of landomycin E to the lanGT1 mutant (A) and to the lanGT4 mutant (B). 1, negative ion
chromatograms; 2, UV-VIS spectra.are now presenting data that clearly shows that two
GTs involved in landomycin A biosynthesis are acting
twice during the assembly of the sugar side chain (Fig-
ure 3).
The function of several GTs involved in antibiotic bio- repeatedly on a growing sugar chain either by overex-
Figure 3. Function of Glycosyltransferases
Involved in the Biosynthesis of Landomy-
cin Asynthesis (e.g., erythromycin, urdamycin A, mithra-
mycin) has been described [6, 16]. In all cases, the
number of sugars matches the number of available
GTs. There are few examples of GTs capable of working
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728ppression [17] or by in vitro studies [18]. But to date, no
wGT has been shown to act twice during natural product
Aformation. Thus, LanGT1 and LanGT4 are the first ex-
D
amples of such iteratively acting GTs. It is likely that c
there are many further natural-product GTs that belong m
tto this new class of iteratively acting GTs. As an exam-
mple, avilamycin A consists of a heptasaccharide chain,
sbut only four putative GT genes have been detected in
the avilamycin biosynthetic gene cluster. This suggests
F
repeated action also for some of the avilamycin GTs. A L
big challenge in the future for the generation of novel g
oligosaccharide antibiotics is to understand the struc- T
Mtural features that allow the unique flexibility of itera-
tively acting GTs.
LIn this study, we recognized another enzyme to be
Sinvolved in the process of the hexasacharide biosyn-
c
thesis of landomycin A. A lanZ2 mutant of S. cyano- 2
genus S136 produced all main landomycin derivatives, w
abut the production was strongly impaired.
fThe amino acid sequence encoded by lanZ2 is sim-
Cilar to dTDP-glucose synthases from different organ-
isms. Because the landomycin biosynthetic gene clus-
H
ter contains a second putative dTDP-glucose synthase H
gene (lanG), both genes were expressed in E. coli, and w
the corresponding enzymes were purified. Only LanG s
cwas able to activate D-glucose-1-phosphate (data not
gshown). In 1997, the existence of a short sugar-activa-
stion pathway in S. cyanogenus S136 was shown by in-
3
corporation of labeled L-rhodinose [19] into the lando- w
mycin molecule. It might be speculated that LanZ2 is t
involved in this short sugar-activation pathway, main- m
ataining the correct flux of TDP-activated deoxysugar in
1the cell.
ASignificance
T
This is the first description of glycosyltransferases m
(LanGT1 and LanGT4) involved in natural-product
biosynthesis and are working iteratively on a growing R
oligosaccharide chain. The olivosyltransferase LanGT1 R
Acatalyzes the transfer of the second and the fourth
Psugar, the rhodinosyltransferase LanGT4 attaches the
third and the sixth sugar during the biosynthesis of
Rthe landomycin A hexasacharide side chain. Appa-
rently, the putative NDP-hexose synthase LanZ2 is re-
quired for the smooth and complete biosynthesis of
the hexasaccharide part of landomycin A.
Experimental Procedures
General Genetic Manipulation
Standard molecular biology procedures were performed as de-
scribed [20]. Isolation of E. coli DNA, DNA restriction, DNA modifi-
cation such as filling-in-sticky ends, and Southern hybridization
were performed following the protocols of the manufacturers of
kits, enzymes, and reagents (Amersham Pharmacia, Boehringer
Mannheim, Promega, Stratagene).
Intergeneric Conjugation between E. coli and S. cyanogenus
Intergeneric conjugation between E. coli and S. cyanogenus was
performed as described earlier [15].
Construction of Gene Inactivation
and Complementation Plasmids
A 4.2 kb BamHI-SphI fragment from cosmid H2-26 [8] containing
the lanZ2 gene was ligated into the same site of pLitmus38 to yieldlasmid pLitZ2. A unique SacI restriction site inside the gene lanZ2
as chosen for targeted inactivation by shifting the reading frame.
fter SacI restriction, treatment with the Klenow fragment of E. coli
NA polymerase I, and religation, the intended alteration was
hecked by DNA sequencing. The 4.2 kb fragment containing the
utated lanZ2 was inserted into the EcoRV site of pKC1132 to yield
he inactivation construct pKC1132lanZ2. The construction of plas-
id pKCermEGT3Z2Z3 used for complementation has been de-
cribed [14].
eeding Experiments
andomycin E (5 mg) was added to a 50 ml liquid culture of S. cyano-
enus S136, S. cyanogenus DlanGT1, and S. cyanogenus DlanGT4.
he production of landomycin derivatives was monitored by HPLC-
S after 48 hr.
andomycin Production and Purification
trains were grown in SG medium (soybean meal, 10 g , l−1; glu-
ose, 20 g , l−1; CaCO3, 2 g , l−1; CoCl2, 1 mg , l−1 [pH 7.2]) for
–4 days at 30°C in a rotary shaker at 200 rpm. The culture broth
as adjusted to pH 7 and extracted with an equal volume of ethyl
cetate. Extracts were dried in vacuo, dissolved in CHCl3, and puri-
ied by column chromatography on silica gel (column 2.5 × 25 cm;
HCl3, MeOH = 96:4).
PLC-ESI-MS
PLC-ESI-MS was performed on an Agilent 1100 series system
ith an electrospray chamber and a quadrupole detector. The LC-
ystem was equipped with a Hewlett Packard ZORBAX SB C-18
olumn (5 m particle size, 4.6 × 150 mm) maintained at 35°C. The
radient profile was: solvent A, 0.5% acetic acid in H2O; and
olvent B, 0.5% acetic acid in CH3CN. An initial hold for 3 min with
0% B was followed by a step gradient from 30% up to 60% B
ithin 16 min and from 60% up to 95% within 3 min and held at
hat relation for further 2 min. The solvent flow rate was 0.7 ml ,
in−1. The UV detection wavelength was 441 nm. Samples were
nalyzed in a negative scan mode with an m/z range from 200 to
500.
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